Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inari Medical Inc
(NQ:
NARI
)
42.03
+0.04 (+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inari Medical Inc
< Previous
1
2
3
4
5
6
Next >
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
March 06, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
February 12, 2023
Find out why the investment bankers who follow these stocks think they can soar in the near term.
Via
The Motley Fool
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
February 07, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Analyst Expectations for Inari Medical's Future
January 31, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Inari Medical
December 20, 2022
Via
Benzinga
Analyst Ratings for Inari Medical
November 03, 2022
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Inari Medical Earnings Preview
February 24, 2023
Via
Benzinga
Analyst Ratings for Inari Medical
February 21, 2023
Via
Benzinga
Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 31, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
January 21, 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses.
Via
The Motley Fool
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis
January 12, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Where Inari Medical Stands With Analysts
September 29, 2022
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:
Via
Benzinga
Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus
May 05, 2022
Via
Benzinga
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
January 10, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
January 07, 2023
These companies are reporting financial results that aren't being reflected in their stock market performances.
Via
The Motley Fool
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
Inari Medical, Inc.
Via
GlobeNewswire
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
December 02, 2022
These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would suggest.
Via
The Motley Fool
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 03, 2022
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Reports Third Quarter 2022 Financial Results
November 02, 2022
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT
October 31, 2022
From
Inari Medical, Inc.
Via
GlobeNewswire
Where Inari Medical Stands With Analysts
October 17, 2022
Over the past 3 months, 6 analysts have published their opinion on Inari Medical (NASDAQ:NARI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Inari Medical to Announce Third Quarter 2022 Financial Results
October 06, 2022
From
Inari Medical, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
September 13, 2022
Upgrades See all analyst ratings upgrades.
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Inari Medical: Here's What You Need To Know
July 15, 2022
Morgan Stanley has decided to maintain its Overweight rating of Inari Medical (NASDAQ:NARI) and lower its price target from $108.00 to $93.00. Shares of Inari Medical are trading up 0.74% over the last...
Via
Benzinga
Inari Medical's Return On Capital Employed Insights
May 23, 2022
Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022
June 21, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.